First Bard Vein Filter Bellwether Heads to Jury

By Cara Salvatore Law360

Law360, Phoenix (March 29, 2018, 11:30 PM EDT) – a Phoenix federal jury began deliberations Thursdays in the first bellwether trial in multidistrict litigation over claims that device maker Bard’s clot-stopping vein implants splinted and migrated toward patients’ hearts after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings . . .

Read Article